COVID Treatment: Govt Approves Use of Dexamethasone Steroid

COVID Treatment: Govt Approves Use of Dexamethasone Steroid

Published27 Jun 2020, 08:39 AM IST
1 min read

The Union Ministry of Health and Family Welfare has released a revised clinical management protocol for treating Covid-19 patients on Saturday, 27 June.

Now moderate and severe patients with coronavirus can be given Dexamethasone steroid as an alternative to Methylprednisolone. These are patients who need oxygen support and experience excessive inflammation.

The MoHFW tweeted the same,

However, this is not a vaccine it is simply part of the treatment plan for dealing with COVID-19 patients.

What is Dexemathasone?

Dexamethasone is cheap, costs less than 30 paise, a strip of 10 comes at Rs 3, and some 20 companies make the drug in India.

Dexamethasone falls under a class of drugs known as corticosteroids and is used to treat a range of inflammatory conditions including arthritis and other rheumatic problems, swelling in the brain, allergies, asthma and other breathing difficulties. Even eye and dental inflammation is often treated by the steroid

(The Quint is now available on Telegram. For handpicked stories every day, subscribe to us on Telegram)

(This story was auto-published from a syndicated feed. No part of the story has been edited by The Quint.)

Never Miss Out

Stay tuned with our weekly recap of what’s hot & cool by The Quint.

Join over 120,000 subscribers!